Insights from SCOPE


  • AI in Clinical Financial Operations: The Hidden Bottleneck

    Insights from SCOPE | Financial operations influence every stage of a clinical trial, yet they remain one of the most overlooked opportunities for AI. Explore how connected financial workflows can reduce administrative burden, improve startup, strengthen site relationships, and create better operational visibility.

    Jul 9, 2026
  • Keeping it Simple: Protocol Simplicity as a Scalability Strategy

    Insights from SCOPE | Protocol complexity affects far more than study design. Explore how simplifying protocols can reduce site burden, improve study startup, strengthen scalability, and help clinical teams focus on collecting the data that matters most for successful trial execution.

    Jul 7, 2026
  • Machine-Readable Protocols: The Foundation of Scalable AI Execution

    Insights from SCOPE | Machine-readable protocols can do more than streamline documentation. They create the structured foundation AI needs to improve study startup, feasibility, and trial execution. Explore why the future of clinical operations may begin with rethinking the protocol itself.

    Jul 2, 2026
  • Operational Intelligence Is Replacing Gut Feel in Study Startup

    Insights from SCOPE | Study startup decisions have traditionally relied on experience and historical data. Discover how operational intelligence, workflow visibility, and AI are helping teams make faster, better-informed decisions before startup risks become execution problems.

    Jun 30, 2026
  • Beyond Startup: Building Sponsor-Site Partnerships That Last

    Insights from SCOPE | Strong sponsor-site partnerships don't begin with startup and end at closeout. Discover how long-term collaboration, operational transparency, and shared learning can reduce friction, improve trial execution, and create lasting value across every study in a development portfolio.

    Jun 25, 2026
  • Clinical Trial Startup Is Slowing Down. Here's Why.

    Insights from SCOPE | Clinical trial startup continues to slow despite growing investment in technology and automation. Explore how protocol complexity, fragmented processes, incomplete operational visibility, and internal misalignment create delays—and why removing friction may matter more than adding new tools.

    Jun 23, 2026
  • Building Recruitment Systems Instead of Recruitment Campaigns

    Insights from SCOPE | Many enrollment challenges begin long before patient outreach starts. Explore why protocol design, site feasibility, community engagement, and patient support function as a connected recruitment system—and why stronger systems often matter more than bigger campaigns.

    Jun 18, 2026
  • Patient Readiness: The Missing Metric in Clinical Trial Recruitment

    Insights from SCOPE | Many patients who qualify for a clinical trial never enroll—not because they lack interest, but because they lack confidence. Explore why patient readiness, trust, education, and practical support may be just as important as eligibility in driving enrollment success.

    Jun 16, 2026
  • Embedding Research Into Routine Care: The Next Phase of Trial Delivery

    Insights from SCOPE | Embedding clinical research into routine care can expand access, reduce patient burden, and improve scalability without compromising oversight. Explore how integrated care pathways, hub-and-spoke models, and pragmatic protocol design are reshaping the next phase of trial delivery.

    Jun 11, 2026
  • Digital Tools at Sites: Closing the Perception Gap

    Insights from SCOPE | Sponsors and sites often see digital adoption differently. Explore how misaligned assumptions, workflow gaps, and integration challenges shape real-world site technology use — and why early collaboration is essential to making digital tools reduce burden instead of increasing it.

    Jun 9, 2026
  • Decentralization as an Operating Model, Not a Feature Set

    Insights from SCOPE | Decentralization only delivers real value when it’s designed as an operating model, not a collection of tools. Explore how flexible, community-integrated trial delivery models are expanding access, reducing burden, and reshaping how research is embedded into routine care.

    Jun 4, 2026
  • The Middle Phase of AI Adoption: Between Experimentation and Autonomy

    Insights from SCOPE | Clinical research is entering a transitional phase of AI adoption — beyond pilots, but not yet autonomous. Explore how modular scaling, human-in-the-loop design, and disciplined governance are shaping the industry’s middle phase and defining what sustainable AI integration truly looks like.

    Jun 2, 2026
  • Regulatory-Grade AI: What It Really Takes to Earn Trust

    Insights from SCOPE | AI in clinical trials must do more than perform accurately. It must be explainable, traceable, and defensible under regulatory scrutiny. Explore what separates experimental AI from regulatory-grade systems built for trust, transparency, and sustainable enterprise deployment.

    May 28, 2026
  • The End of Isolated Automation: Rebuilding Clinical Operations Around Intelligent Systems

    Insights from SCOPE | AI will not transform clinical trials by automating isolated tasks. Real impact comes when workflows are redesigned around structured data, coordinated execution, and built-in governance. Explore how organizations are moving beyond incremental efficiency toward intelligent clinical operating models.

    May 26, 2026
  • The Signals That Defined SCOPE X: Where AI Is Actually Moving Clinical Research

    Insights from SCOPE | Following up on SCOPE X, one message stands out: AI impact depends less on model sophistication and more on data foundations, workflow redesign, governance, and measurable business value. Explore the signals shaping how clinical research is embedding AI responsibly and at scale.

    May 21, 2026
  • Is Your AI Delivering Real Business Value? Here's How to Know

    Insights from SCOPE | AI in clinical development is shifting from experimentation to measurable business impact. Explore where artificial intelligence is truly driving value across startup, enrollment, governance, and portfolio strategy — and why strong data foundations and oversight determine long-term success.

    May 19, 2026
  • Key Questions Every Clinical Leader Should Be Asking About AI in 2026

    Insights from SCOPE | Clinical leaders are moving beyond AI experimentation and into real operational decisions. Explore five strategic questions that will shape how artificial intelligence transforms clinical trial design, execution, governance, and human oversight in 2026 and beyond.

    May 14, 2026
  • 5 Practical Use Cases for AI in Clinical Operations

    Insights from SCOPE | AI in clinical research has moved beyond pilots. From study startup to risk monitoring and recruitment coordination, real-world use cases are already delivering measurable impact. Explore five practical applications transforming clinical operations before the conversation continues at SCOPE X.

    May 12, 2026
  • Rethinking Rare Disease Recruitment in the Era of Genomic Data

    Insights from SCOPE | Challenges around rare disease recruitment aren't always about patient volume. Precision matters. When eligibility depends on specific mutations or biomarkers, traditional funnels fall short. Learn how mutation-aware outreach and structured data can connect the right patients to the right trials faster.

    May 7, 2026
  • Bringing Real-World Data Upstream in Patient Recruitment Planning

    Insights from SCOPE | Most recruitment challenges don’t begin when enrollment stalls. They start months earlier in protocol design and feasibility assumptions. Learn how bringing real-world data upstream can prevent downstream delays, reduce screen failures, and improve enrollment predictability before the first patient is contacted.

    May 5, 2026
SCOPE of Things Podcast